Francisco J. Rodríguez

Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

Lihteh Wu, María Ana Martinez-Castellanos, Hugo Quiroz–Mercado et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2007 · 454 citations

Ocular Disease, Vitreous Body, Experimental Ophthalmology +4

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Night blindness in Sorsby's fundus dystrophy reversed by vitamin A

Samuel G. Jacobson, Artur V. Cideciyan, G. Regunath et al. · Nature Genetics · 1995 · 218 citations

Ocular Disease, Night Blindness, Ophthalmology +4

FUNCTIONAL AND ANATOMICAL SIGNIFICANCE OF THE ECTOPIC INNER FOVEAL LAYERS IN EYES WITH IDIOPATHIC EPIRETINAL MEMBRANES

Andrea Govetto, Gianni Virgili, Francisco J. Rodríguez et al. · Retina · 2017 · 144 citations · Full text

Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema

J. Fernando Arévalo, J. García Sánchez, Lihteh Wu et al. · Ophthalmology · 2009 · 125 citations · Full text

Diabetic Retinopathy, Ocular Disease, Vitreous Body +5